A Humanized Bone Metastasis Model: Ex Vivo and In Vivo Applications

Area of Science:

• Oncology
• Biomedical Engineering
• Translational Medicine

Background:

• Bone metastasis from breast and prostate cancer leads to skeletal complications.
• Developing effective treatments is hindered by a lack of reliable preclinical models.

Purpose of the Study:

• To create a humanized bone metastasis model using human bone and cancer cells.
• To evaluate the model's utility for studying bone metastasis and testing treatments.

Main Methods:

• Human bone discs and metastatic cancer cells were combined to form bone metastasis discs.
• These discs were cultured ex vivo or implanted subcutaneously into nude mice.
• Bioluminescence tracked cancer cell activity, and histology assessed bone changes.

Main Results:

• Ex vivo cultures showed metabolically active cells but no lesion formation.
• Subcutaneous implantation resulted in osteolytic metastatic lesions in vivo within 3-6 weeks.
• Cisplatin reduced cancer cell signals ex vivo but not in vivo.

Conclusions:

• A proof-of-concept humanized ex vivo/in vivo bone metastasis model was established.
• The model requires further optimization for robustness and quantification.
• This model holds potential for evaluating novel bone metastasis therapies.